Works by MAYAKO UCHIDA
Results: 59
Evaluation of Cardiac Adverse Events with Nivolumab Using a Japanese Real-World Database.
- Published in:
- Clinical Drug Investigation, 2023, v. 43, n. 3, p. 177, doi. 10.1007/s40261-023-01246-x
- By:
- Publication type:
- Article
Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 10, p. 2636, doi. 10.1002/ijc.21680
- By:
- Publication type:
- Article
Monitoring for potential adverse drug reactions in patients receiving chemotherapy.
- Published in:
- American Journal of Health-System Pharmacy, 2004, v. 61, n. 22, p. 2366, doi. 10.1093/ajhp/61.22.2366
- By:
- Publication type:
- Article
Eye-tracking-based analysis of pharmacists' thought processes in the dispensing work: research related to the efficiency in dispensing based on right-brain thinking.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00341-1
- By:
- Publication type:
- Article
Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 9, p. 893, doi. 10.1002/phar.1294
- By:
- Publication type:
- Article
Evaluation of lung adverse events with nivolumab using the spontaneous reporting system in Japan.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-35602-w
- By:
- Publication type:
- Article
Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medications.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1195732
- By:
- Publication type:
- Article
Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 4, p. 343, doi. 10.2146/ajhp120363
- By:
- Publication type:
- Article
Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS).
- Published in:
- Journal of Pharmacy & Pharmaceutical Sciences, 2021, v. 24, p. 499, doi. 10.18433/jpps31862
- By:
- Publication type:
- Article
Disproportionality Analysis of Stomatitis Associated with Anticancer Drugs Using the Japanese Adverse Drug Event Report Database.
- Published in:
- Oncology, 2024, v. 102, n. 9, p. 810, doi. 10.1159/000535331
- By:
- Publication type:
- Article
Evaluation of Time to Onset and Outcome of Cardiac Adverse Events Associated with Nilotinib using Post-Marketing Surveillance.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 799, doi. 10.1159/000533325
- By:
- Publication type:
- Article
Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing Surveillance.
- Published in:
- Oncology, 2023, v. 101, n. 12, p. 817, doi. 10.1159/000533302
- By:
- Publication type:
- Article
Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 664, doi. 10.1159/000531390
- By:
- Publication type:
- Article
Evaluation of Cardiac Adverse Events with Ponatinib Using a Spontaneous Reporting Database.
- Published in:
- Oncology, 2023, v. 101, n. 6, p. 397, doi. 10.1159/000529768
- By:
- Publication type:
- Article
Cardiac Adverse Events Associated with Multiple Myeloma Patients Treated with Proteasome Inhibitors.
- Published in:
- Oncology, 2023, v. 101, n. 5, p. 343, doi. 10.1159/000529341
- By:
- Publication type:
- Article
Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database.
- Published in:
- Oncology, 2022, v. 100, n. 7, p. 413, doi. 10.1159/000524806
- By:
- Publication type:
- Article
Comprehensive Analysis of Bortezomib-Induced Adverse Events Using the Japanese Real-World Database.
- Published in:
- Oncology, 2022, v. 100, n. 3, p. 188, doi. 10.1159/000521448
- By:
- Publication type:
- Article
Evaluation of Cardiac Adverse Events Associated with Carfilzomib Using a Japanese Real-World Database.
- Published in:
- Oncology, 2022, v. 100, n. 1, p. 60, doi. 10.1159/000519687
- By:
- Publication type:
- Article
Risk Factor for Rash in Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 5, p. 617, doi. 10.21873/cdp.10372
- By:
- Publication type:
- Article
Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 396, doi. 10.21873/invivo.13841
- By:
- Publication type:
- Article
Evaluation of Times-to-onset and Outcomes of Lung Adverse Events Associated With Sorafenib Using JADER.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 360, doi. 10.21873/invivo.13836
- By:
- Publication type:
- Article
Evaluation of Lung Adverse Events Associated With Lenvatinib: A Post-marketing Surveillance Study.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 346, doi. 10.21873/invivo.13834
- By:
- Publication type:
- Article
Evaluation of the Time to Onset and Outcome of Lenalidomide-induced Thrombosis and Embolism Using Spontaneous Reporting Database.
- Published in:
- In Vivo, 2023, v. 37, n. 3, p. 1246, doi. 10.21873/invivo.13201
- By:
- Publication type:
- Article
Assessment of Time-to-onset and Outcome of Lung Adverse Events With Pomalidomide from a Pharmacovigilance Study.
- Published in:
- In Vivo, 2023, v. 37, n. 2, p. 955, doi. 10.21873/invivo.13168
- By:
- Publication type:
- Article
Usefulness of a Medication Instruction Sheet for Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid Leukemia.
- Published in:
- In Vivo, 2023, v. 37, n. 2, p. 924, doi. 10.21873/invivo.13164
- By:
- Publication type:
- Article
The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER.
- Published in:
- In Vivo, 2023, v. 37, n. 1, p. 345, doi. 10.21873/invivo.13085
- By:
- Publication type:
- Article
Evaluation of Medication Instruction Sheets for Patients Undergoing R-CHOP Therapy in Non-Hodgkin's Lymphoma.
- Published in:
- In Vivo, 2022, v. 36, n. 3, p. 1461, doi. 10.21873/invivo.12852
- By:
- Publication type:
- Article
Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study.
- Published in:
- JGH Open, 2023, v. 7, n. 2, p. 87, doi. 10.1002/jgh3.12868
- By:
- Publication type:
- Article
Comprehensive analysis of everolimus‐induced adverse events using the Japanese real‐world database.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 8, p. 1173, doi. 10.1111/jcpt.13648
- By:
- Publication type:
- Article
Evaluation of a web‐based educational programme for pharmacists during the COVID‐19 pandemic in Japan.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 6, p. 1743, doi. 10.1111/jcpt.13526
- By:
- Publication type:
- Article
Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2024, v. 32, n. 1, p. 279, doi. 10.1007/s40199-024-00516-z
- By:
- Publication type:
- Article
Association between a low dose of proton pump inhibitors and kidney function decline in elderly hypertensive patients: a retrospective observational study.
- Published in:
- Journal of International Medical Research, 2021, v. 49, n. 4, p. 1, doi. 10.1177/03000605211006653
- By:
- Publication type:
- Article
Differential profiles of adverse events associated with mycophenolate mofetil between adult and pediatric renal transplant patients.
- Published in:
- Journal of International Medical Research, 2018, v. 46, n. 11, p. 4617, doi. 10.1177/0300060518786917
- By:
- Publication type:
- Article
Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40780-019-0149-z
- By:
- Publication type:
- Article
A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40780-019-0143-5
- By:
- Publication type:
- Article
Inhibitory Effect of α1 Receptor Antagonists on Paclitaxel-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database.
- Published in:
- Toxics, 2022, v. 10, n. 11, p. 669, doi. 10.3390/toxics10110669
- By:
- Publication type:
- Article
Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Omeprazole Suppresses Oxaliplatin-Induced Peripheral Neuropathy in a Rodent Model and Clinical Database.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 8859, doi. 10.3390/ijms23168859
- By:
- Publication type:
- Article
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8733, doi. 10.3390/ijms22168733
- By:
- Publication type:
- Article
Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1393, doi. 10.3390/ijms22031393
- By:
- Publication type:
- Article
Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 7, p. 5831, doi. 10.1007/s00520-022-07002-9
- By:
- Publication type:
- Article
Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0278823
- By:
- Publication type:
- Article
Disproportionality analysis of cardiac adverse events associated with lenvatinib using the Japanese Adverse Drug Event Report database.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 12, p. 3348, doi. 10.1111/bcp.16237
- By:
- Publication type:
- Article
Improvement of Blood Pressure Control by Adherence Check in Patients With Apparent Treatment-Resistant Hypertension: A Case Series.
- Published in:
- Clinical Medicine Insights: Case Reports, 2020, v. 13, p. 1, doi. 10.1177/1179547620904884
- By:
- Publication type:
- Article
Improvement of Blood Pressure Control by Adherence Check in Patients With Apparent Treatment-Resistant Hypertension: A Case Series.
- Published in:
- Clinical Medicine Insights: Case Reports, 2020, p. 1, doi. 10.1177/1179547620904884
- By:
- Publication type:
- Article
Drug-induced tubulointerstitial nephritis in a retrospective study using spontaneous reporting system database.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 9, p. 1159, doi. 10.1177/1060028014539919
- By:
- Publication type:
- Article
Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88460-9
- By:
- Publication type:
- Article